These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18765163)

  • 1. Drug-eluting stents: is new necessarily better?
    Waksman R
    Lancet; 2008 Sep; 372(9644):1126-8. PubMed ID: 18765163
    [No Abstract]   [Full Text] [Related]  

  • 2. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial.
    Windecker S; Serruys PW; Wandel S; Buszman P; Trznadel S; Linke A; Lenk K; Ischinger T; Klauss V; Eberli F; Corti R; Wijns W; Morice MC; di Mario C; Davies S; van Geuns RJ; Eerdmans P; van Es GA; Meier B; Jüni P
    Lancet; 2008 Sep; 372(9644):1163-73. PubMed ID: 18765162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable drug-eluting stents: promises and pitfalls.
    Di Mario C; Ferrante G
    Lancet; 2008 Mar; 371(9616):873-4. PubMed ID: 18342665
    [No Abstract]   [Full Text] [Related]  

  • 4. The bioabsorption process: tissue and cellular mechanisms and outcomes.
    Vorpahl M; Finn AV; Nakano M; Virmani R
    EuroIntervention; 2009 Dec; 5 Suppl F():F28-35. PubMed ID: 22100673
    [No Abstract]   [Full Text] [Related]  

  • 5. Coronary artery aneurysm formation within everolimus-eluting bioresorbable stent.
    Şerban R; Scridon A; Dobreanu D; Elkaholut A
    Int J Cardiol; 2014 Nov; 177(1):e4-5. PubMed ID: 25129265
    [No Abstract]   [Full Text] [Related]  

  • 6. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very late stent thrombosis with newer drug-eluting stents: no longer an issue?
    de la Torre Hernández JM; Windecker S
    Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):595-8. PubMed ID: 22627073
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term follow-up of the First In Man experience with everolimus-eluting stents.
    Kimmelstiel C
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):1004-5. PubMed ID: 20517960
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-eluting stents - what should be improved?
    Steffel J; Eberli FR; Lüscher TF; Tanner FC
    Ann Med; 2008; 40(4):242-52. PubMed ID: 18428018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Very late stent thrombosis after implantation of sirolimus eluting coronary stents].
    Xu L; Wang LF; Yang XC; Ge YG; Wang HS; Li WM; Ni ZH; Liu Y; Xia K; Cui L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):312-5. PubMed ID: 17711654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
    Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL
    Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extremely late drug-eluting stent thrombosis related to uncovered struts: the phantom menace.
    Spagnoli V; Veugeois A; Caussin C; Amabile N
    Eur Heart J; 2013 Aug; 34(31):2428. PubMed ID: 23821398
    [No Abstract]   [Full Text] [Related]  

  • 14. Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomised trial.
    Lemos PA; Moulin B; Perin MA; Oliveira LA; Arruda JA; Lima VC; Lima AA; Caramori PR; Medeiros CR; Barbosa MR; Brito FS; Ribeiro EE
    EuroIntervention; 2012 May; 8(1):117-9. PubMed ID: 22580255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial.
    Kereiakes DJ; Meredith IT; Windecker S; Lee Jobe R; Mehta SR; Sarembock IJ; Feldman RL; Stein B; Dubois C; Grady T; Saito S; Kimura T; Christen T; Allocco DJ; Dawkins KD
    Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25855680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very late acquired peri-stent contrast staining and incomplete stent apposition with biodegradable polymer stents: insight from optical coherence tomography.
    Takashima H; Sakurai S; Waseda K; Kurita A; Ando H; Kumagai S; Amano T
    Int J Cardiol; 2014 Sep; 176(1):e11-2. PubMed ID: 25085382
    [No Abstract]   [Full Text] [Related]  

  • 17. A generation 2.5 drug-eluting stent?
    Ellis SG
    JACC Cardiovasc Interv; 2009 Oct; 2(10):986-8. PubMed ID: 19850259
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: rationale and design of the BIOSCIENCE trial.
    Pilgrim T; Roffi M; Tüller D; Muller O; Vuilliomenet A; Cook S; Weilenmann D; Kaiser C; Jamshidi P; Heg D; Jüni P; Windecker S
    Am Heart J; 2014 Sep; 168(3):256-61. PubMed ID: 25173535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary aneurysm formation following biodegradable polymer drug-eluting stent implantation.
    Zhang F; Qian J; Dong L; Ge J
    Int J Cardiol; 2012 Sep; 160(1):e8-9. PubMed ID: 22257689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.